Sumary of FDA requests removal of strongest warning against statin use among pregnant women:
- July 20, 2021 1 min read ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on .
- Back to Healio The FDA requested removal of its contraindication against using cholesterol-lowering statin medicines among pregnant patients;
- however, most patients should stop statins once they learn they are pregnant.
- Source: Adobe Stock According to an FDA press release, statins may prevent major adverse events among certain high-risk patients who are pregnant;
- therefore, contraindicating statin therapy for all pregnant women is not appropriate.
- The FDA added that patients who are breastfeeding should halt statin therapy, as the drug may pass into breast milk and pose a risk to the baby, and many can resume treatment when breastfeeding ends.
- According to the release, patients requiring ongoing statin therapy should not breastfeed and instead use infant formula or other alternatives.